Secondaries announced 9.14.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: BCB Bancorp, Inc.
Symbol: BCBP
Price: Last trade $11.00
Trade Date: wk of 9/21
Shares: 3.6 million
Underwriter(s) Sandler O’Neill & Partners
Rating=Subscription Needed

Company: Mirati Therapeutics
Symbol: MRTX
Price: Last trade $46.29
Trade Date: 9/16
Shares: 1.73 million
Underwriter(s) Citigroup, Barclays, Leerink Swann
Rating=Subscription Needed